IN2015DN03069A - - Google Patents
Info
- Publication number
- IN2015DN03069A IN2015DN03069A IN3069DEN2015A IN2015DN03069A IN 2015DN03069 A IN2015DN03069 A IN 2015DN03069A IN 3069DEN2015 A IN3069DEN2015 A IN 3069DEN2015A IN 2015DN03069 A IN2015DN03069 A IN 2015DN03069A
- Authority
- IN
- India
- Prior art keywords
- extracts
- compositions
- antiʌ
- dermatological
- antimicrobial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
Abstract
Compositions and methods of treatment are disclosed using compositions of extracts from the fruit of the Synsepalum dulcificum tree, which when applied topically in mammals, can provide benefit for dermatological and joint conditions. The extracts also contain antiʌ inflammatory, antimicrobial and spermicidal activity in vitro.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261700981P | 2012-09-14 | 2012-09-14 | |
PCT/US2013/059374 WO2014043304A1 (en) | 2012-09-14 | 2013-09-12 | Topical compositions and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2015DN03069A true IN2015DN03069A (en) | 2015-10-02 |
Family
ID=50274700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3069DEN2015 IN2015DN03069A (en) | 2012-09-14 | 2013-09-12 |
Country Status (14)
Country | Link |
---|---|
US (1) | US20140079657A1 (en) |
EP (1) | EP2895181B1 (en) |
JP (2) | JP6271554B2 (en) |
KR (2) | KR102175015B1 (en) |
CN (1) | CN104812398B (en) |
AU (1) | AU2013315536B2 (en) |
BR (1) | BR112015005339B1 (en) |
CA (1) | CA2883389C (en) |
HK (1) | HK1212251A1 (en) |
IL (1) | IL237421B (en) |
IN (1) | IN2015DN03069A (en) |
MX (1) | MX367091B (en) |
SG (2) | SG10201913382YA (en) |
WO (1) | WO2014043304A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104812398B (en) * | 2012-09-14 | 2020-01-21 | 奇迹果油有限公司 | Topical compositions and methods of use thereof |
CN106999512A (en) * | 2014-09-18 | 2017-08-01 | 葛兰素史克消费保健(美国) 控股有限责任公司 | New preparation |
US10941310B2 (en) * | 2016-03-25 | 2021-03-09 | The Sherwin Williams Company | Non-skid, textured protective coating compositions for vehicle surfaces |
CN105456140B (en) * | 2015-12-29 | 2018-05-08 | 广州栋方生物科技股份有限公司 | A kind of sprouting composition and preparation method thereof |
CA3018866C (en) | 2016-03-31 | 2024-03-26 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
EP3436156A1 (en) | 2016-03-31 | 2019-02-06 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
WO2017205659A1 (en) * | 2016-05-26 | 2017-11-30 | Dermala Inc. | Compositions and methods for treating acne vulgaris |
WO2018098152A1 (en) | 2016-11-23 | 2018-05-31 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
TWI787423B (en) * | 2017-12-26 | 2022-12-21 | 福岡大太朗 | Pharmaceutical composition for increasing hair, scalp or skin modification, wound healing, bone formation promotion, or hair modification |
CN108611032A (en) * | 2018-05-16 | 2018-10-02 | 爱尔美(北京)生物科技有限公司 | A kind of novel environment-friendly water-based first piece binder and preparation method thereof |
CN108451894B (en) * | 2018-06-28 | 2021-01-08 | 山东师范大学 | Curcumin carrier with temperature responsiveness |
US20200323935A1 (en) * | 2019-04-10 | 2020-10-15 | G.I. Pharmaceuticals, Inc. dba E2BIO CONSULTANTS, INC. | Novel method for the treatment of dyspepsia, food and medicine intolerances, irritable bowel syndrome and other functional gastrointestinal conditions |
FR3109883B1 (en) * | 2020-05-07 | 2022-04-15 | Oreal | HAIR TREATMENT COMPOSITIONS |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4330664A1 (en) * | 1993-09-10 | 1995-03-16 | Beiersdorf Ag | Uses of vegetable oils |
JP2001122732A (en) * | 1999-10-26 | 2001-05-08 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing moisturizing plant extract |
JP2002316937A (en) * | 2001-04-19 | 2002-10-31 | Ichimaru Pharcos Co Ltd | Plant extract-containing anti-allergic agent |
US20030059489A1 (en) * | 2001-09-24 | 2003-03-27 | Canolio Inc. | Genital lubricating compositions and uses thereof |
JP3766018B2 (en) * | 2001-12-17 | 2006-04-12 | 一丸ファルコス株式会社 | Active oxygen scavenger |
JP2005298667A (en) * | 2004-04-12 | 2005-10-27 | Fuji Latex Kk | Lubricant and condom coated with the same lubricant |
JP2006265118A (en) * | 2005-03-22 | 2006-10-05 | Takeda-Kirin Foods Corp | Antibacterial agent and antibacterial composition containing extract of plant of family sapotaceae |
US20080199533A1 (en) * | 2007-02-21 | 2008-08-21 | Delarosa Dan M | Cosmetic and skin care formulation containing pearls, teas and fruits |
CA2735889A1 (en) * | 2008-09-10 | 2010-03-18 | Silipos, Inc. | Gelatinous elastomer compositions |
CN102743421A (en) * | 2012-07-12 | 2012-10-24 | 万福群 | Synsepalum dulcificum Denill tree branch and leaf extract and extraction method and application of extract |
CN104812398B (en) * | 2012-09-14 | 2020-01-21 | 奇迹果油有限公司 | Topical compositions and methods of use thereof |
-
2013
- 2013-09-12 CN CN201380047613.4A patent/CN104812398B/en active Active
- 2013-09-12 BR BR112015005339-4A patent/BR112015005339B1/en not_active IP Right Cessation
- 2013-09-12 SG SG10201913382YA patent/SG10201913382YA/en unknown
- 2013-09-12 AU AU2013315536A patent/AU2013315536B2/en active Active
- 2013-09-12 KR KR1020197030044A patent/KR102175015B1/en active IP Right Grant
- 2013-09-12 IN IN3069DEN2015 patent/IN2015DN03069A/en unknown
- 2013-09-12 WO PCT/US2013/059374 patent/WO2014043304A1/en active Application Filing
- 2013-09-12 SG SG11201501381PA patent/SG11201501381PA/en unknown
- 2013-09-12 EP EP13837852.6A patent/EP2895181B1/en active Active
- 2013-09-12 CA CA2883389A patent/CA2883389C/en active Active
- 2013-09-12 US US14/024,898 patent/US20140079657A1/en not_active Abandoned
- 2013-09-12 MX MX2015003239A patent/MX367091B/en active IP Right Grant
- 2013-09-12 JP JP2015532033A patent/JP6271554B2/en active Active
- 2013-09-12 KR KR1020157009646A patent/KR20150056820A/en not_active Application Discontinuation
-
2015
- 2015-02-25 IL IL237421A patent/IL237421B/en active IP Right Grant
-
2016
- 2016-01-14 HK HK16100377.5A patent/HK1212251A1/en unknown
-
2017
- 2017-12-27 JP JP2017251250A patent/JP6752771B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2895181B1 (en) | 2020-04-22 |
BR112015005339A2 (en) | 2017-07-04 |
CN104812398A (en) | 2015-07-29 |
AU2013315536B2 (en) | 2018-08-09 |
SG11201501381PA (en) | 2015-04-29 |
JP6752771B2 (en) | 2020-09-09 |
IL237421A0 (en) | 2015-04-30 |
HK1212251A1 (en) | 2016-06-10 |
KR20150056820A (en) | 2015-05-27 |
CA2883389C (en) | 2020-04-21 |
JP2018083826A (en) | 2018-05-31 |
BR112015005339B1 (en) | 2021-05-18 |
JP2015535214A (en) | 2015-12-10 |
KR102175015B1 (en) | 2020-11-05 |
CA2883389A1 (en) | 2014-03-20 |
AU2013315536A1 (en) | 2015-04-16 |
JP6271554B2 (en) | 2018-01-31 |
MX2015003239A (en) | 2015-10-09 |
WO2014043304A1 (en) | 2014-03-20 |
KR20190122854A (en) | 2019-10-30 |
MX367091B (en) | 2019-08-05 |
SG10201913382YA (en) | 2020-03-30 |
IL237421B (en) | 2020-03-31 |
CN104812398B (en) | 2020-01-21 |
EP2895181A4 (en) | 2016-03-30 |
US20140079657A1 (en) | 2014-03-20 |
BR112015005339A8 (en) | 2019-08-13 |
EP2895181A1 (en) | 2015-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2015DN03069A (en) | ||
AU2018236800B2 (en) | DNA-PK inhibitors | |
MX2018006578A (en) | Topical pharmaceutical formulations for treating inflammatory-related conditions. | |
MX2020009780A (en) | Autotaxin inhibitor compounds. | |
WO2014188276A3 (en) | Antioxidant compositions and methods of using the same | |
MX2018005829A (en) | Compositions for treating the hair. | |
EP4299122A3 (en) | Compositions and methods for treating skin and mucous membrane diseases | |
WO2012125544A3 (en) | Necroptosis inhibitors and methods of use therefor | |
WO2013078259A3 (en) | Oil compositions and methods for increasing hair growth and/or preventing hair loss | |
EP2558124A4 (en) | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization | |
MX2015009045A (en) | Compositions and methods for treating severe pain. | |
IN2015DN01524A (en) | ||
EP3131524A4 (en) | Methods and compositions for topical delivery for skin care | |
MX2014009750A (en) | Antifungal compositions for the treatment of skin and nails. | |
MX350970B (en) | Methods and compositions for extending shelf life of plant products. | |
MX2015003074A (en) | Formulations comprising idebenone, n-acetyl-s-farnesyl-l-cysteine and ergothioneine and uses thereof. | |
WO2012024399A3 (en) | Compositions comprising paulownin and/or paulownia extracts and uses thereof | |
GB201213484D0 (en) | Pharmaceutical compositions comprising 15-OHEPA and methods of using the same | |
MX2018007871A (en) | Personal care composition comprising taurine, arginine, glycine. | |
WO2013023059A3 (en) | Methods and compositions for the treatment of autoimmune and inflammatory diseases | |
MX344189B (en) | Formulations of mazindol. | |
MX363385B (en) | Treatment of sickle cell disease and inflammatory conditions. | |
MX2015013151A (en) | Methods of treating dyskinesia and related disorders. | |
MX345263B (en) | Stable pexiganan formulation. | |
EP4233915A3 (en) | Modified release formulations of viloxazine |